Inventor · disambiguated record
Ann Hsu
Also filed as: HSU ANN · HSU ANN F
26 granted patents·9 pending applications·354 citations·filing 2002–2025
97Inventor score
Top patents by PatentIndex Score
35 records- 0198US11666538B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2022·Granted Jun 6, 2023·16 cites·21 claims
- 0298US11622941B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2021·Granted Apr 11, 2023·16 cites·29 claims
- 0398US11357733B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2021·Granted Jun 14, 2022·20 cites·40 claims
- 0498US10987313B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2019·Granted Apr 27, 2021·29 cites·44 claims
- 0598US10973769B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2020·Granted Apr 13, 2021·28 cites·27 claims
- 0697US10688058B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2019·Granted Jun 23, 2020·32 cites·22 claims
- 0797US10292935B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2016·Granted May 21, 2019·30 cites·20 claims
- 0897US8377474B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2008·Granted Feb 19, 2013·48 cites·82 claims
- 0996US12178919B2Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2024·Granted Dec 31, 2024·1 cites·23 claims
- 1095US12064521B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2023·Granted Aug 20, 2024·1 cites·20 claims
- 1195US10098845B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2014·Granted Oct 16, 2018·28 cites·22 claims
- 1293US12403099B2Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2024·Granted Sep 2, 2025·0 cites·19 claims
- 1393US12303605B2Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2024·Granted May 20, 2025·0 cites·26 claims
- 1493US12274793B2Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2024·Granted Apr 15, 2025·0 cites·22 claims
- 1592US12178918B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2024·Granted Dec 31, 2024·0 cites·21 claims
- 1692US12128141B1Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2024·Granted Oct 29, 2024·0 cites·18 claims
- 1791US12491164B2Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2025·Granted Dec 9, 2025·0 cites·19 claims
- 1891US8007827B2Pharmaceutical dosage forms having immediate release and/or controlled release propertiesIMPAX LABORATORIES INC·Filed 2005·Granted Aug 30, 2011·17 cites·45 claims
- 1990US7094427B2Combination immediate release controlled release levodopa/carbidopa dosage formsIMPAX LABORATORIES INC·Filed 2002·Granted Aug 22, 2006·60 cites·31 claims
- 2089US8557283B2Controlled release formulations of levodopa and uses thereofHSU ANN·Filed 2012·Granted Oct 15, 2013·9 cites·9 claims
- 2188US9089608B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2013·Granted Jul 28, 2015·6 cites·21 claims
- 2286US9089607B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2013·Granted Jul 28, 2015·5 cites·56 claims
- 2384US8454998B2Controlled release formulations of levodopa and uses thereofHSU ANN·Filed 2012·Granted Jun 4, 2013·5 cites·30 claims
- 2482US9463246B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2013·Granted Oct 11, 2016·3 cites·54 claims
- 2565US9901640B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2016·Granted Feb 27, 2018·0 cites·25 claims
- 2661US9533046B2Controlled release formulations of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2015·Granted Jan 3, 2017·0 cites·31 claims
- 2750US2004097484A1Once a day galantamine pharmaceutical compositions and methods of useFiled 2002·Application pending·0 cites
- 2849US2005220864A1Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonistHAN CHIEN-HSUAN·Filed 2004·Application pending·0 cites
- 2949US2005220873A1Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonistHAN CHIEN-HSUAN·Filed 2004·Application pending·0 cites
- 3049US2005220874A1Pharmaceutical dosage forms having immediate release and controlled release properties that contain a GABAB receptor agonistHAN CHIEN-HSUAN·Filed 2004·Application pending·0 cites
- 3149US2005220863A1Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonistHAN CHIEN-HSUAN·Filed 2004·Application pending·0 cites
- 3248US2005147670A1Oral disintegrating dosage formsIMPAX LABORATORIES INC·Filed 2004·Application pending·0 cites
- 3347US2005226927A1Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonistIMPAX LABORATORIES INC·Filed 2005·Application pending·0 cites
- 3442US2004166159A1Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopaFiled 2004·Application pending·0 cites
- 3539US2006013875A1Combination immediate release controlled release levodopa/carbidopa dosage formsIMPAX LABORATORIES INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ann Hsu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →